Evidence map›Paper›PMID 33467621›Full record

ReviewJournal of clinical medicine2021

Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach.

Angel L Montejo, Rubén de Alarcón, Nieves Prieto, José Mª Acosta, Bárbara Buch, Laura Montejo

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. A Pragmatic Approach to Sexual Health in Movement Disorders.Movement disorders clinical practice · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Influence ofCanadian journal of psychiatry. Revue canadienne de psychiatrie · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. New Challenges in Sexuality and Sexual Dysfunction.Journal of clinical medicine · 2022
    Article
  15. Article
  16. Article
  17. Erectile dysfunction as a marker of endocrine and glycemic disorders.Journal of endocrinological investigation · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Angel L MontejoPsychiatry Service, Clinical Hospital of the University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-4383-1333
Rubén de AlarcónPsychiatry Service, Infanta Elena Hospital, Juan Ramon Jiménez Hospital, Ronda Exterior Norte S/N, 21080 Huelva, Spain.
Nieves PrietoPsychiatry Service, Clinical Hospital of the University of Salamanca, 37007 Salamanca, Spain.
José Mª AcostaInstitute of Biomedical Research of Salamanca (IBSAL), Paseo San Vicente SN, 37007 Salamanca, Spain.
Bárbara BuchInstitute of Biomedical Research of Salamanca (IBSAL), Paseo San Vicente SN, 37007 Salamanca, Spain.
Laura MontejoBarcelona Bipolar and Depressive Disorders Program, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Hospital Clinic of Barcelona, 08401 Catalonia, Spain.
Instituto de Investigación Biomédica de Salamanca · ESUniversidad de Salamanca · ESCentro de Investigación Biomédica en Red de Salud Mental · ESHospital Juan Ramón Jiménez · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antipsychotic medication can be often associated with sexual dysfunction (SD). Given its intimate nature, treatment emergent sexual dysfunction (TESD) remains underestimated in clinical practice. However, psychotic patients consider sexual issues as important as first rank psychotic symptoms, and their disenchantment with TESD can lead to important patient distress and treatment drop-out. In this paper, we detail some management strategies for TESD from a clinical perspective, ranging from prevention (carefully choosing an antipsychotic with a low rate of TESD) to possible pharmacological interventions aimed at improving patients' tolerability when TESD is present. The suggested recommendations include the following: prescribing either aripiprazole or another dopaminergic agonist as a first option antipsychotic or switching to it whenever possible. Whenever this is not possible, adjunctive treatment with aripiprazole seems to also be beneficial for reducing TESD. Some antipsychotics, like olanzapine, quetiapine, or ziprasidone, have less impact on sexual function than others, so they are an optimal second choice. Finally, a variety of useful strategies (such as the addition of sildenafil) are also described where the previous ones cannot be applied, although they may not yield as optimal results.

Indexed as

anorgasmiaantipsychoticerectile dysfunctionmanagement strategiesorgasm retardationsexual dysfunctionTESDtreatment

Identifiers

PMID33467621
PMCPMC7829881
OpenAlexW3120901239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.